(Q77466547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

0 references

1 reference

title

Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

Steven Warach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

11-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

Tissue plasminogen activator for acute ischemic stroke

5 December 2019

cites work

1 reference

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

21 January 2018

1 reference

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

21 January 2018

1 reference

Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke

21 January 2018

1 reference

Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging

21 January 2018

1 reference

Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset.

21 January 2018

1 reference

New imaging strategies for patient selection for thrombolytic and neuroprotective therapies

21 January 2018

1 reference

Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

21 January 2018

1 reference

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI

21 January 2018

1 reference

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782978%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference